Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Remifentanil and Atropine for Intubation in Neonates (RAIN)

This study has been completed.
McMaster University
Information provided by:
King Saud University Identifier:
First received: December 24, 2008
Last updated: December 26, 2008
Last verified: December 2008

December 24, 2008
December 26, 2008
January 2006
February 2008   (Final data collection date for primary outcome measure)
Time to Successful intubation [ Time Frame: 15 minutes ]
Same as current
No Changes Posted
  • Time to return of spontaneous respirations [ Time Frame: 15 minutes ]
  • Oxygen saturation [ Time Frame: During the procedure up to 15 minutes ]
  • Heart Rate [ Time Frame: During the procedure up to 15 minutes ]
  • Blood Pressure [ Time Frame: During the procedure up to 15 minutes ]
  • Intubation Condition [ Time Frame: 15 minutes post procedure ]
  • Evidence of Trauma [ Time Frame: 15 minutes post procedure ]
Same as current
Not Provided
Not Provided
Remifentanil and Atropine for Intubation in Neonates
Remifentanil and Atropine for Intubation in Neonates; a Randomized Controlled Trial
The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.
Not Provided
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Endotracheal Intubation
  • Drug: Atropine/Remifentanil

    Atropine 20mcg/kg

    Remifentanil 3mcg/kg

  • Drug: Fentanyl/Atropine/Succinylcholine

    Atropine 20mcg/kg

    Fentanyl 2mcg/kg

    Succinylcholine 2mg/kg

  • Active Comparator: Remifentanil



    Intervention: Drug: Atropine/Remifentanil
  • Placebo Comparator: Fentanyl




    Intervention: Drug: Fentanyl/Atropine/Succinylcholine
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
February 2008
February 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hemodynamically stable neonates of any gestational age admitted to the Neonatal Intensive Care Unit at McMaster Children's Hospital requiring an elective endotracheal intubation was anticipated.

Exclusion Criteria:

  • Urgent intubations
  • Cyanotic congenital heart lesions
  • Anticipated difficult airway
  • Concurrent or recently administered (within 3 hours of the procedure) intravenous opioid infusions
  • Pre-existing hyperkalemia
  • Family history of malignant hyperthermia
  • Prior enrollment
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Khalid AlFaleh, King Saud University
King Saud University
McMaster University
Principal Investigator: Khalid M Alfaleh, MBBS, MSc King Saud University
Study Director: Karen Choong, FRCPC McMaster University
King Saud University
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP